U.S. Markets closed

SHAREHOLDER ALERT: Immunomedics, Inc. (IMMU) Sued for Misleading Shareholders; The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm

HENDERSONVILLE, TN / ACCESSWIRE / September 16, 2019 / The Law Offices of Timothy L. Miles, who has been leading the fight to protect shareholder rights for over 18 years, announces that purchasers of Immunomedics, Inc. (IMMU) filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1934 between August 23, 2018 and December 20, 2018. Immunomedics, a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer.

Immunomedics, Inc. (IMMU) Accused of Data Integrity Breach

According to the complaint, on December 17, 2018, FDAnews.com published an article, stating that "[t]he FDA cited Immunomedics for a host of violations - including its handling of a data integrity breach - observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14." The breach purportedly included "manipulated bioburden samples, misrepresentations of in integrity test procedure in the batch record, and backdating of batch records, such as dates of analytical results." On December 20, 2018, Favus Institutional Research issued its own report discussing the data integrity breach. On this news, Immunomedics' stock fell 20% to close at $14.17 on December 20, 2018.

The Law Offices of Timothy L. Miles Encourages Immunomedics Shareholders to Contact the Firm

If you purchased Immunomedics securities, have information, or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Timothy L. Miles, Esquire, at 615-587-7384, Toll-Free at 855-846-6529, or by email to tmiles@timmileslaw.com. If you inquire by email please include your mailing address, telephone number, and the number shares purchased.


About Timothy L. Miles

Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles was recentely selected as a 2019 Elite Lawyer of The South by Martindale-Hubbell® and ALM, and was also recently named as a recipient of the Lifetime Achievement Award by Premier Lawyers of America, a prestigious, invitation-only organization which recognizes the best lawyers in America. Mr Miles maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics and is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, maintains a superb rated attorney by Avvo, and was recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Awards: 2019 Elite Lawyer of The South by Martindale-Hubbell® and ALM (2019); Member of the Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association (2017-2019); AV® Preeminent™ Rating by Martindale-Hubble® (2014-2019); PRR AV Preeminent Rating on Lawyers.com (2017 & 2019); The Top-Rated Lawyer in Litigation™ for Ethical Standards and Legal Ability (Martindale-Hubble® 2015); Distinguished Lawyer, Recognizing Excellence in Securities Law, Lawyers of Distinction (2019); Superb Rated Attorney (Avvo); Avvo Top Rated Lawyer for 2017 & 2018 (Avvo).

Contact:

Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
124 Shiloh Ridge
Hendersonville, TN 37075
Telephone: (855-846-6529)
Email: tmiles@timmileslaw.com Website: www.timmileslaw.com

SOURCE: The Law Offices of Timothy L. Miles



View source version on accesswire.com:
https://www.accesswire.com/559916/SHAREHOLDER-ALERT-Immunomedics-Inc-IMMU-Sued-for-Misleading-Shareholders-The-Law-Offices-of-Timothy-L-Miles-Encourages-Immunomedics-Shareholders-to-Contact-the-Firm